Clinical trial

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

NCT06164574

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-11-01

PhaseN/A

Study timeline

Study start (actual)2022-11-01Date precision: day

Registry last updated2023-12-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Survival analysisOTHER

Sponsors & collaborators

Haiquan Chenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06164574 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.